Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | Note 10 – Stock Options Stock Option Plans On July 27, 2010, the Company’s Board of Directors adopted the 2010 Stock Incentive Plan (the “2010 Plan”). The aggregate number of shares of common stock that could be granted under the 2010 Plan was reset at the beginning of each year based on 15% of the number of shares of common stock then outstanding. As such, on January 1, 2016 the number of shares of common stock available under the 2010 Plan was reset to 5,719,069 shares based upon 38,127,129 shares outstanding on that date. Options were typically granted with an exercise price equal to the estimated fair value of the Company's common stock at the date of grant with a vesting schedule of one to three years and a contractual term of 5 years. As discussed below, the 2010 Plan has been replaced by a new stock option plan and no additional stock option grants will be granted under the 2010 Plan. As of September 30, 2016, there were options to purchase 2,350,668 shares outstanding under the 2010 Plan. On July 18, 2016, the Board of Directors unanimously approved the adoption of the Enservco Corporation 2016 Stock Incentive Plan (the “2016 Plan”), which was approved by the stockholders on September 29, 2016. The aggregate number of shares of common stock that may be granted under the 2016 Plan is 8,000,000 shares plus authorized and unissued shares from the 2010 Plan totaling 2,391,711 for a total reserve of 10,391,711 shares. As of September 30, 2016, there were options to purchase 1,960,000 shares outstanding under the 2016 Plan. A summary of the range of assumptions used to value stock options granted for the three and nine months ended September 30, 2016 and 2015 are as follows: For the T hree M onths E nded For the Nine Months Ended September 30, September 30, 2016 2015 2016 2015 Expected volatility 81% - 104% - 81% - 102% 107 - 109% Risk-free interest rate 0.6% - 0.9% - 0.9% - 1.2% 0.75 - 0.86% Forfeiture rate 0% - 0% 0% Dividend yield - - - - Expected term (in years) 0.1 - 3.3 - 3.1 - 3.5 3.4 During the nine months ended September 30, 2016, the Company granted options to acquire 3,525,000 shares of common stock with a weighted-average grant-date fair value of $0.28 per share. During the nine months ended September 30, 2016, no options were exercised. During the nine months ended September 30, 2015, the Company granted options to acquire 1,123,500 shares of common stock with a weighted-average grant-date fair value of $1.19 per share. During the nine months ended September 30, 2015, options to acquire 720,333 shares of common stock were exercised by way of a cashless exercise whereby the option holders elected to receive 550,276 shares of common stock by paying the exercise price for such shares by canceling the remaining options for 170,057 shares. The options had an intrinsic value of $1,131,371 at the time of exercise. In addition, options to acquire 404,667 shares of common stock were exercised for cash payments of $198,285. The options had an intrinsic value of $423,837 at the time of exercise. The following is a summary of stock option activity for all equity plans for the nine months ended September 30, 2016: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31 , 2015 3,485,168 $ 1.31 2.53 $ 63,067 Granted 3,525,000 0.78 Exercised - - Forfeited or Expired (2,699,500 ) 0.93 Outstanding at September 30, 2016 4,310,668 $ 1.11 3.12 $ 54,100 Vested or Expected to Vest at September 30, 2016 4,310,668 $ 1.11 3.12 $ 54,100 Exercisable at September 30, 2016 2,042,832 $ 1.23 1.92 $ 31,600 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the estimated fair value of the Company’s common stock on September 30, 2016, and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they exercised their options on September 30, 2016. As discussed below in the Forfeiture and Grant of Stock Option s During the nine months ended September 30, 2016 and 2015, the Company recognized stock-based compensation costs for stock options of $493,458 and $442,243, respectively in general and administrative expenses. During the three months ended September 30, 2016 and 2015, the Company recognized stock-based compensation costs for stock options of $175,954 and $170,972, respectively. The Company currently expects all outstanding options to vest. Compensation cost is revised if subsequent information indicates that the actual number of options vested due to service is likely to differ from previous estimates. A summary of the status of non-vested shares underlying the options are presented below: Number of Shares Weighted-Average Grant-Date Fair Value Non-vested at December 31, 2015 1,323,669 $ 1.22 Granted 3,525,000 0.28 Vested (1,401,333 ) 0.55 Forfeited or Expired (1,179,500 ) 0.53 Non-vested at September 30, 2016 2,267,836 $ 0.53 As of September 30, 2016, there was $924,960 of total unrecognized compensation costs related to non-vested shares under the qualified stock option plans which will be recognized over the remaining weighted-average period of 1.6 years. Forfeiture and Grant of Stock Options On June 17, 2016, the Board of Directors appointed a special committee of disinterested directors (the “Special Committee”) to address certain claims in a letter dated June 14, 2016 from an attorney purporting to represent a stockholder of the Company regarding the Company’s 2010 Stock Incentive Plan (the “2010 Plan”) and equity awards granted thereunder. After investigation and consultation with special counsel, the Special Committee verified that certain stock options granted under the 2010 Plan had exceeded an applicable limitation in the 2010 Plan. On July 7, 2016, the Special Committee unanimously approved: (a) the rescission (and forfeiture by the holders) of certain stock option awards to purchase 2,560,000 shares of the Company’s common stock that had been granted to various officers and directors in excess of the 2010 Plan’s limitations (“Excess Shares”), and (b) the grant of new options to purchase 1,960,000 shares of the Company’s common stock (the “New Options”), pursuant to the 2016 Plan. The New Options were subject to: (i) each of the option holders entering into a rescission letter agreement with the Company and (ii) stockholder approval of the 2016 Plan. On July 18, 2016, the Board of Directors unanimously approved the adoption of the 2016 Plan, which after stockholder approval thereof, replaced the 2010 Plan. Further, the Company entered into rescission letter agreements with the various executive officers and directors whereby each such officer/director agreed to forfeit their Excess Shares. The Company agreed to grant the New Options pursuant to new stock option agreements that provide for vesting on substantially the same schedule as the Excess Shares would have vested but could not have been exercised prior to stockholder approval of the 2016 Plan on September 29, 2916. The exercise price of the New Options is the greater of the original exercise price of the Excess Shares or the closing market price on July 7, 2016, the date the Special Committee approved the New Options. Under the letter agreements, the termination date of each New Option is the termination date of the rescinded option, except that if the termination date of the rescinded option is prior to the two-year anniversary of the date of the letter agreement, then the termination date of the New Option is extended six months past the termination date of the rescinded option. Further, the Company agreed to submit the 2016 Plan to the stockholders of the Company for approval and on September 29, 2016, the stockholders approved the 2016 Plan. In November 2016, the Special Committee reached a settlement with the attorney and stockholder that sent the initial demand letter and agreed to pay an immaterial amount in settlement of the matter above. |